. . . . . . . . . . . . "p(HGNC:OSM) -| bp(GO:\"cell proliferation\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "OM treatment caused coordinate changes of mRNA expression of several cell cycle components including c/EBPdelta, cdc20, and thymidine kinase 1 (TK1) that mainly affect G1-S phase transition. antiproliferative activity of OM" . . "Selventa" . . . . "2014-07-03T14:30:15.228+02:00"^^ . . .